New drug for Alzheimer's disease shows efficacy in mid-stage clinical trials by US company

An American pharmaceutical company has announced that mid-stage clinical trials have confirmed the effectiveness of a new type of treatment for Alzheimer's disease, which is currently being raced around the world to suppress the progression of symptoms.